Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Alkem Laboratories Ltd.
NSE: ALKEM
|
BSE: 539523
|
ISIN: INE540L01014
|
Industry: Pharmaceuticals
|
Falling Comet
4906.5000
62.00
(
1.28
%)
NSE
Aug 12, 2025
10:13 AM
Volume:
9,192
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Alkem Laboratories Ltd.
08 Nov 2023
4906.50
1.28%
Alkem Labs (HOLD): Sizeable margin gains; tax guided to reduce raise to HOLD
Hold:
Alkem Laboratories Ltd.
by
BOB Capital Markets Ltd.
Target: 3850
Recommendation
Target
BOB Capital Markets Ltd.
Q2 EBITDA/PAT outstripped consensus by 44%/54% on higher margins, strong US growth and low taxes
Number of FII/FPI investors increased from 535 to 551 in Jun 2025 qtr.
More from Alkem Laboratories Ltd.
Recommended
Market opens flat, Astral's Q1FY26 net profit declines 32.6% YoY to Rs 81.1 crore
Trendlyne Marketwatch |
12 Aug 2025, 10:09AM
IPO action stays active with four new issues and six listings this week
|
11 Aug 2025, 06:17PM
Alkem Laboratories hopes to fire up its US business to fuel future growth
|
02 Jul 2021